DexCom (DXCM) Stock Price, Quote, News & History | Benzinga

DexCom Inc (DXCM) Stock Price, Quote, News & History

DXCMNASDAQ

Trade with Public

Trade with Public

$92.34

2.122.35%

At close: Aug 21, 5:00 PM EST

$92.40

0.06390.07%

After Hours: Aug 21, 7:55 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$89.61

Close

$92.34

Volume / Avg.

3.48M / 5.32M

Day Range

$89.20 - $92.56

52 Wk Range

54.11 - 92.56

Market Cap

$34.87B

P/E Ratio

36.50

Dividend Yield

-

Exchange

NASDAQ

RSI

73

Short Interest

5.37%

Days to Cover

3.45

Recent Dexcom Inc News

Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion

Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cycle highs.

Piero Cingari

AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Moving Higher On Friday

U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other gainers include NWL, FET, IESC, SPXC, AMZN, SPSC, DLB, GH, DXCM, and MPWR.

Avi Kapoor

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page for full coverage.

Avi Kapoor

Dexcom Scores Pediatric Expansion For OTC Stelo Glucose Monitor

FDA Clears Dexcom's OTC Stelo CGM For Children Ages 2 And Older, Expanding Access To Real-Time Glucose Monitoring.

Vandana Singh

Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes

DexCom CONNECT trial found G7 reduced A1C and improved glucose control in Type 2 diabetes patients not using insulin.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.75B

Investing Cash Flow (TTM)

530.70M

Financing Cash Flow (TTM)

-2.33B

Free Cash Flow (TTM)

1.41B

Capital Expenditure (TTM)

-343.70M

Net Change in Cash (TTM)

-50.10M

Analyst Trends and Forecast

6

2

May

5

Jun

12

1

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$34.30B

PE Ratio (TTM)

36.50

PE Ratio (FWD)

36.50

PEG Ratio (TTM)

1.74

PS Ratio (TTM)

7.39

PB Ratio (TTM)

13.29

Earnings Yield % (TTM)

2.74%

Earnings Yield % (FWD)

2.74%

EV / EBITDA (TTM)

22.00

Price / EBITDA (TTM)

23.54

Price / Free Cash Flow (TTM)

26.12

Book Value / Share

$6.95

Company Debt

Total Debt

$1.24B

LT Debt

$1.24B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$1.11B

Debt to Equity

0.53

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$89.61

Close

$92.34

Volume / Avg.

3.48M / 5.32M

Day Range

$89.20 - $92.56

52 Wk Range

54.11 - 92.56

Market Cap

$34.87B

P/E Ratio

36.50

Dividend Yield

-

Exchange

NASDAQ

RSI

73

Short Interest

5.37%

Days to Cover

3.45

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy DexCom (DXCM) stock?

A

You can purchase shares of DexCom (NASDAQ:DXCM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are DexCom (DXCM) competitors?

A

Other companies in DexCom’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for DexCom (DXCM) stock?

A

DexCom has a consensus price target of $89.69.

Q

What is the current price for DexCom (DXCM)?

A

The stock price for DexCom (NASDAQ: DXCM) is $92.4039 last updated August 21, 2026 at 7:55 PM EDT.

Q

Does DexCom (DXCM) pay a dividend?

A

There are no upcoming dividends for DexCom.

Q

When is DexCom (NASDAQ:DXCM) reporting earnings?

A

DexCom does not have any upcoming earnings scheduled.

Q

Is DexCom (DXCM) going to split?

A

There is no upcoming split for DexCom.

Q

What sector and industry does DexCom (DXCM) operate in?

A

DexCom is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.